Displaying items 25-36 of 585
» View wsbtradio.com items only
< Previous
1
2
3
4
5
6
7
8
9
10
11-49
Next >
-
RPT-PREVIEW-Immunotherapy is not just for melanoma anymore
Reuters(Repeats for wider distribution. No changes to headline or text) By Julie Steenhuysen and Deena Beasley CHICAGO/LOS ANGELES, May 31 (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tartaglia was loath to undergo the kind of harsh...Tags: Health Treatments, Health and Safety at School, Renal cell carcinoma, Lung Cancer, New Haven (New Haven, Connecticut)
-
Voice of the People, May. 27
Jolie's decision Angelina Jolie's decision to undergo testing for mutations in the BRCA1 and BRCA2 genes and then to undergo a double mastectomy to reduce her risk for breast and ovarian cancer was prompted by her family history. The Society of...Tags: Abortion Issue, Medical Specialization, Social Issues, Abortion, MRI (imaging)
-
Synta drug shown to extend lives of certain lung cancer patients
ReutersCHICAGO, June 3 (Reuters) - A drug designed to block a protein known to help cancer cells grow was shown in a mid-stage trial to lengthen survival in patients with advanced lung cancer that worsened after initial treatment, researchers said on Monday....Tags: Chemotherapy, Biotechnology, Health Treatments, Lung Cancer, Medical Research
-
Roche's Avastin extends life in advanced cervical cancer
ReutersBy Bill Berkrot June 3 (Reuters) - Roche Holding AG's drug Avastin helped prolong the lives of women with advanced cervical cancer when added to chemotherapy in a late-stage clinical trial, likely paving the way to another major use for the multibillion-...Tags: Chemotherapy, Biotechnology, Health Treatments, Roche Holding AG, Bevacizumab (drug)
-
Outlook changing for PSA screening
For nearly a quarter-century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that its benefits outweigh the risks — especially when tiny, slow-growing tumors were detected....
Tags: Erectile Dysfunction, Symptoms, General Practitioners, Prostate Cancer, Medical Specialization
-
ANALYSIS-Biotech's bull run starts to look frothy
ReutersBy Deena Beasley May 28 (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the...Tags: Stock Activities, S&P 500, Rentals, Earnings, Companies and Corporations
-
Decoding Angelina Jolie's double mastectomy and BRCA genes
Angelina Jolie’s revelation that she underwent a preventative double mastectomy may seem like a shocking move to some. But for many women who have dangerous hereditary risks coded into their genes, this kind of surgery before cancer strikes serves...
Tags: Mastectomy, Angelina Jolie, Ovarian Cancer, Tamoxifen (drug), Breast Cancer
-
Star's preventive surgery sparks breast cancer debate
Angelina Jolie's announcement Tuesday that a genetic predisposition to breast and ovarian cancer led her to undergo a preventive double mastectomy has raised both awareness about the procedure and concerns among physicians and other experts. The actress...
Tags: General Practitioners, Dermatologists, Collagen Injections, Health and Medical Professionals, Internists
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: AstraZeneca Plc, Roche Holding AG, Health Treatments, Novartis AG, Amgen Inc.
-
Elizabeth Vega Casey: Women with breast cancer gene have treatment choices
The Morning Call may not be The New York Times, but I have to acknowledge that I am not Angelina Jolie either. But there are similarities. Let me explain. Firstly, I want to take a moment to sincerely applaud her decision to reveal through The New York...Tags: Mastectomy, Angelina Jolie, The New York Times, News Media, Tamoxifen (drug)
-
Philip Nivatpumin named medical director of Kaufman Cancer Center at Upper Chesapeake
Upper Chesapeake Health (UCH) is pleased to announce that it has named Dr. Philip Nivatpumin has been named by Upper Chesapeake Health as medical director of the UCH Patricia D. and M. Scot Kaufman Cancer Center. The Kaufman Cancer Center is currently...Tags: Medical Specialization, Internal Medicine, Drugs and Medicines, Health and Medical Professionals, Internists
-
Pfizer halts study of lymphoma drug unlikely to help survival
ReutersMay 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was...Tags: Chemotherapy, Hodgkin's Lymphoma, Biotechnology, Health Treatments, Cancer
May 31, 2013
|Story| Reuters
May 27, 2013
|Story| Chicago Tribune
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 1, 2013
|Story| Baltimore Sun
May 28, 2013
|Story| Reuters
May 14, 2013
|Story| Los Angeles Times
May 14, 2013
|Story| Chicago Tribune
May 22, 2013
|Story| Reuters
May 21, 2013
|Story| Allentown Morning Call
May 13, 2013
|Story| Baltimore Sun
May 20, 2013
|Story| Reuters
Original site for Oncology topic gallery.